At Vision Expo West, Nicholas J. Bruns, OD, FAAO, discussed the benefits of the cyclosporine Vevye, which has a newer vehicle that improves penetration and speed. The pivotal trials show that Vevye starts showing success in 2 weeks, faster than previous versions of cyclosporine, with symptom improvement continuing for over 52 weeks. Bruns also recommends considering other options for treating dry eye, as it is a multi-faceted issue that needs to be tackled from different angles. This information was shared in a video on Healio, emphasizing the importance of exploring different treatment approaches for dry eye.
Source link